SB486
Gluten disclaimer; required disclosures for dietary supplements and medication.
Status:
In Senate
Latest Action:
Feb. 5, 2026
Senate: Passed by for the day (Voice Vote)
Chief Patron:
Richard Stuart (R)
Session:
2026 Regular Session
Summary
As Introduced. Required disclosures for dietary supplements and medication; gluten disclaimer.
Requires any person who manufactures, distributes, or sells or offers for sale a dietary supplement to label such dietary supplement with a list of active and inactive ingredients and include a separate disclaimer if the product contains gluten. The bill requires pharmacists, when dispensing a prescription drug, to provide all ... (More) information required under federal law to accompany the drug, including the medication guide, patient package insert, or other written patient information. The bill also requires pharmacists to provide counseling consistent with federally required labels to patients upon request when dispensing a nonprescription drug. (Less)-
Bill History
- 01/13/2026 - Senate: Prefiled and ordered printed; Offered 01-14-2026 26105005D
- 01/13/2026 - Senate: Referred to Committee on Education and Health
- 01/27/2026 - Senate: Assigned Education sub: Health
- 01/29/2026 - Senate: Reported from Education and Health and rereferred to Finance and Appropriations (15-Y 0-N)
- 01/29/2026 - Senate: Rereferred to Finance and Appropriations
- 01/30/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB486)
- 02/04/2026 - Senate: Reported from Finance and Appropriations with substitute (15-Y 0-N)
- 02/04/2026 - Senate: Senate committee offered
- 02/05/2026 - Senate: Committee substitute printed 26107162D-S1
- 02/05/2026 - Senate: Rules suspended
- 02/05/2026 - Senate: Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
- 02/05/2026 - Senate: Passed by for the day (Voice Vote)
